Tessari Eben
SEC insider (Form 3/4/5 filer). CIK 0001867899. CHIEF STRATEGY OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA). 101 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in LONDON.
Companies Tessari Eben has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Officer, CHIEF STRATEGY OFFICER
Tessari Eben
CIK: 0001867899
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kiniksa Pharmaceuticals International, plc
Discretionary Trading P&L
Holdings
Transaction History (101 total)
- Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect846 shares at avg. $48.94$41K - Apr 7, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.7K shares- - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
33.2K shares- - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectPerformance Share Unit
16.6K shares- - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Unit
8.3K shares- - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect6K shares- - Apr 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
Tax PaymentDirect1.8K shares at avg. $48.13$85K - Jan 15, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirect365 shares at avg. $24.16$9K - Dec 15, 2025KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect6K shares at avg. $8.83$53K - Dec 15, 2025KNSA
Kiniksa Pharmaceuticals International, plc
SaleDirect12K shares at avg. $41.56$501K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 846 | $48.94 | $41,403 | Direct |
| Apr 7, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,726 | - | $0 | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 33,200 | - | - | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Performance Share Unit | 16,600 | - | - | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Unit | 8,300 | - | - | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 5,975 | - | $0 | Direct |
| Apr 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Tax Payment | 1,756 | $48.13 | $84,516 | Direct |
| Jan 15, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award | 365 | $24.16 | $8,818 | Direct |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 6,000 | $8.83 | $52,980 | Direct |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 12,048 | $41.56 | $500,715 | Direct |
1-10 of 101 transactions